FDA issues multiple RECALLS of blood pressure and cholesterol drugs over contamination and mislabeling The Food and Drug Administration (FDA) announced nationwide recalls of blood pressure and cholesterol medications due to contamination with cancer-causing toxins (nitrosamines), mislabeled packaging and cross-contamination with other drugs—highlighting systemic failures in pharmaceutical manufacturing and regulation. Over 580,000 bottles of prazosin hydrochloride (Minipress/Prazin) were recalled after testing revealed N-nitroso Prazosin, a DNA-damaging nitrosamine linked to cancer in animal studies. The FDA classified it as serious but stopped short of declaring an emergency. Unichem Pharmaceuticals recalled 60,000 doxazosin tablets for misprinted labels, raising concerns about quality control at its…